老年晚期慢性肾脏病患者低蛋白饮食的安全性
EQUAL 研究为前瞻性观察性研究,纳入≥65 岁、eGFR<20 ml/min/1.73 m2 的晚期 CKD 患者 1738 例,随访 6 年。结果显示,处方低蛋白饮食(≤0.8 g/kg 理想体重)与死亡及营养状态下降风险无显著差异,提示在常规临床实践中该饮食对老年人可能安全。
要点
- 老年晚期 CKD 患者处方低蛋白饮食≤0.8 g/kg 与死亡和营养状态下降风险无显著相关。
- 低蛋白饮食<0.6 g/kg 理想体重时结果相似,未显示额外安全性信号。
- 年龄>75 岁、较低 SGA 和较高合并症负担与低蛋白饮食存在显著交互作用。
核心结论
- 在接近终末期肾病的老年 CKD 患者中,按欧洲常规临床实践处方和监测的传统低蛋白饮食似乎是安全的。
研究设计与样本
- EQUAL 研究为前瞻性观察性研究,纳入 6 个欧洲国家≥65 岁、eGFR<20 ml/min/1.73 m2 的 1738 例患者,随访至 6 年。
- 营养状态每 3-6 个月用 7 分主观全面评估(SGA)评估,每次访视记录处方饮食(g 蛋白质/kg 体重),三个国家有实测蛋白质摄入。
- 采用边际结构模型(动态逆概率治疗和删失加权)分析死亡时间和营养状态下降(SGA 下降≥2 分)。
主要发现
- 1738 例中 631 例在随访期间任一时点被处方低蛋白饮食;1319 例有重复 SGA 测量,其中 267 例(20%)SGA 下降≥2 分,565 例(32.5%)死亡。
- 调整模型中,处方低蛋白饮食≤0.8 g/kg 理想体重与死亡(OR 1.15,95%CI 0.86-1.55)和 SGA 下降(OR 1.11,95%CI 0.74-1.66)无显著差异。
- 处方低蛋白饮食<0.6 g/kg 理想体重时结果相似。
- 低蛋白饮食与年龄>75 岁、较低 SGA 和较高合并症负担对死亡和营养状态下降均存在显著交互作用。
临床怎么用
- 对老年晚期 CKD 患者,按常规临床实践处方和监测低蛋白饮食(≤0.8 g/kg 理想体重)未显示增加死亡或营养状态下降风险。
- 对年龄>75 岁、SGA 较低或合并症负担较高的患者,低蛋白饮食与不良结局存在交互作用,需加强营养状态监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A low-protein diet (LPD) is recommended to patients with advanced chronic kidney disease (CKD), whereas geriatric guidelines recommend a higher amount of protein. The aim of this study was to evaluate the safety of LPD treatment in older adults with advanced CKD. METHODS: The EQUAL study is a prospective, observational study including patients ≥65 years of age with an incident estimated glomerular filtration rate <20 ml/min/1.73 m2 in six European countries with follow-up through 6 years. Nutritional status was assessed by a 7-point subjective global assessment (SGA) every 3-6 months. Prescribed diet (g protein/kg of bodyweight) was recorded on every study visit; measured protein intake was available in three countries. Time to death and decline in nutritional status (SGA decrease of ≥2 points) were analysed using marginal structural models with dynamic inverse probability of treatment and censoring weights. RESULTS: Of 1738 adults (631 prescribed LPD at any point during follow-up), there were 1319 with repeated SGA measurements, of which 267 (20%) decreased in SGA ≥2 points and 565 (32.5%) who died. There was no difference in survival or decrease in nutritional status for patients prescribed a LPD ≤0.8 g/kg ideal bodyweight {odds ratio [OR] for mortality 1.15 [95% confidence interval (CI) 0.86-1.55)] and OR for decrease in SGA 1.11 [95% CI 0.74-1.66]} in the adjusted models. In patients prescribed a LPD <0.6 g/kg ideal bodyweight, the results were similar. There was a significant interaction with LPD and older age >75 years, lower SGA and higher comorbidity burden for both mortality and nutritional status decline. CONCLUSIONS: In older adults with CKD approaching end-stage kidney disease, a traditional LPD prescribed and monitored according to routine clinical practice in Europe appears to be safe.
引用
- Windahl K, Chesnaye NC, Irving GF, et al. The safety of a low-protein diet in older adults with advanced chronic kidney disease. Nephrol Dial Transplant. 2024. PMID: 38544335. doi:10.1093/ndt/gfae077
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。